Taurine and N-Bromotaurine in Topical Treatment of Psoriasis

Adv Exp Med Biol. 2022:1370:99-111. doi: 10.1007/978-3-030-93337-1_9.


Psoriasis is a chronic skin auto-inflammatory and systemic disorder. Novel treatments are needed to solve a plethora of cases refractory to current treatment regimens. N-bromotaurine (TauNH-Br), a natural taurine oxidizing derivative produced by inflammatory cells, has anti-inflammatory, antiproliferative, and antimicrobial properties. This evidence prompted us to use TauNH-Br as a local agent for treatment of therapy-refractory psoriasis. Two pustular-plaque psoriasis cases, unresponsive to systemic and local treatments, one with localized lesions and one with generalized lesions, were selected. Both applications primarily indicated a sufficient curative activity of 1% TauNH-Br in psoriasis lesions. Moreover, TauNH-Br co-administration with taurine and a novel olive oil formulation cut in half the time needed for TauNH-Br alone to cause the same regression of equivalent psoriasis plaque lesions in the same patient. Importantly, all adverse effects of TauNH-Br (erythema, itching, bleeding) could be minimized by the combination therapy. Periods of 2-7 weeks to achieve almost complete regression with this formulation were remarkably short as compared to conventional treatment regimens that both patients had followed previously. Of note, there was no relapse within 3 months of monitoring. Combination formulations containing TauNH-Br and olive oil could become an advantageous topical medication for treatment of psoriasis.

Keywords: N-bromotaurine; Olive oil; Sulfur metabolism; Taurine; Topical psoriasis treatment.

MeSH terms

  • Administration, Topical
  • Exanthema*
  • Humans
  • Olive Oil / therapeutic use
  • Psoriasis* / drug therapy
  • Taurine / analogs & derivatives
  • Taurine / pharmacology
  • Taurine / therapeutic use


  • Olive Oil
  • Taurine
  • N-bromotaurine